Literature DB >> 19527537

From idealistic rookies to a regional leader: the history of health technology assessment in Poland.

Rafał Nizankowski1, Norbert Wilk.   

Abstract

In 1989, Poland started to slowly release itself not only from the burden of a half-century of communist indoctrination and soviet exploitation, but also from the consequences of the Semashko model of healthcare organization: low doctors' salaries, primary care based on multispecialty groups, overdeveloped hospital infrastructure, and limited access to sophisticated interventions overcome by patients' unofficial payments. A few years after the 1998 workshop on health technology assessment (HTA) in Budapest, the first HTA reports were elaborated in the National Center for Quality Assessment in Health Care, which could mark the beginning of HTA in Poland. Several individuals and organizations have been involved in developing HTA, both from noncommercial and commercial standpoints. A goal to establish a national HTA agency appeared among the priorities of the Polish Ministry of Health in 2004 and was realized a year later. The Agency for HTA in Poland published guidelines on HTA and established a sound and transparent two-step (assessment-appraisal) process for preparing recommendations on public financing of both drugs and nondrug technologies. The recommendations of the Agency's Consultative Council were warmly welcomed by the public payer. However, the recent major restructuring of the Agency and new drug reimbursement decisions aroused doubts as to keeping transparency of the decision-making processes.

Entities:  

Mesh:

Year:  2009        PMID: 19527537     DOI: 10.1017/S0266462309090588

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  5 in total

1.  Role of centralized review processes for making reimbursement decisions on new health technologies in Europe.

Authors:  Tania Stafinski; Devidas Menon; Caroline Davis; Christopher McCabe
Journal:  Clinicoecon Outcomes Res       Date:  2011-08-30

Review 2.  EQ-5D in Central and Eastern Europe: 2000-2015.

Authors:  Fanni Rencz; László Gulácsi; Michael Drummond; Dominik Golicki; Valentina Prevolnik Rupel; Judit Simon; Elly A Stolk; Valentin Brodszky; Petra Baji; Jakub Závada; Guenka Petrova; Alexandru Rotar; Márta Péntek
Journal:  Qual Life Res       Date:  2016-07-29       Impact factor: 4.147

Review 3.  Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.

Authors:  Aris Angelis; Ansgar Lange; Panos Kanavos
Journal:  Eur J Health Econ       Date:  2017-03-16

4.  Towards a more transparent HTA process in Poland: new Polish HTA methodological guidelines.

Authors:  Krzysztof Lach; Michal Dziwisz; Cécile Rémuzat; Mondher Toumi
Journal:  J Mark Access Health Policy       Date:  2017-07-26

5.  HTA Implementation Roadmap in Central and Eastern European Countries.

Authors:  Zoltán Kaló; Adrian Gheorghe; Mirjana Huic; Marcell Csanádi; Finn Boerlum Kristensen
Journal:  Health Econ       Date:  2016-01-14       Impact factor: 3.046

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.